Literature DB >> 11781346

The buzz about BAFF.

David L Vaux1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11781346      PMCID： PMC150827          DOI： 10.1172/JCI14780

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  28 in total

Review 1.  Apoptosis genes and autoimmunity.

Authors:  D L Vaux; R A Flavell
Journal:  Curr Opin Immunol       Date:  2000-12       Impact factor: 7.486

2.  Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity.

Authors:  M Yan; S A Marsters; I S Grewal; H Wang; A Ashkenazi; V M Dixit
Journal:  Nat Immunol       Date:  2000-07       Impact factor: 25.606

3.  Immunology. Lymphocyte survival--ignorance is BLys.

Authors:  Y Laâbi; A Strasser
Journal:  Science       Date:  2000-08-11       Impact factor: 47.728

4.  Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.

Authors:  J Zhang; V Roschke; K P Baker; Z Wang; G S Alarcón; B J Fessler; H Bastian; R P Kimberly; T Zhou
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

5.  Pharmacokinetics and immunological effects of exogenously administered recombinant human B lymphocyte stimulator (BLyS) in mice.

Authors:  T J Parry; T A Riccobene; S J Strawn; R Williams; R Daoud; J Carrell; S Sosnovtseva; R C Miceli; C M Poortman; L Sekut; Y Li; J Fikes; C Sung
Journal:  J Pharmacol Exp Ther       Date:  2001-02       Impact factor: 4.030

6.  Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response.

Authors:  R K Do; E Hatada; H Lee; M R Tourigny; D Hilbert; S Chen-Kiang
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

7.  BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population.

Authors:  J S Thompson; P Schneider; S L Kalled; L Wang; E A Lefevre; T G Cachero; F MacKay; S A Bixler; M Zafari; Z Y Liu; S A Woodcock; F Qian; M Batten; C Madry; Y Richard; C D Benjamin; J L Browning; A Tsapis; J Tschopp; C Ambrose
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

8.  TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation.

Authors:  X Z Xia; J Treanor; G Senaldi; S D Khare; T Boone; M Kelley; L E Theill; A Colombero; I Solovyev; F Lee; S McCabe; R Elliott; K Miner; N Hawkins; J Guo; M Stolina; G Yu; J Wang; J Delaney; S Y Meng; W J Boyle; H Hsu
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

Review 9.  APRIL and BAFF connect autoimmunity and cancer.

Authors:  C F Ware
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

10.  BAFF mediates survival of peripheral immature B lymphocytes.

Authors:  M Batten; J Groom; T G Cachero; F Qian; P Schneider; J Tschopp; J L Browning; F Mackay
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307
View more
  5 in total

Review 1.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

Review 2.  B-cell survival factors in autoimmune rheumatic disorders.

Authors:  Sandra A Morais; Andreia Vilas-Boas; David A Isenberg
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-08       Impact factor: 5.346

3.  DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF.

Authors:  Amanda L Gavin; Djemel Aït-Azzouzene; Carl F Ware; David Nemazee
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

4.  APRIL modulates B and T cell immunity.

Authors:  Jens V Stein; Marta López-Fraga; Fernando A Elustondo; Carla E Carvalho-Pinto; Dolores Rodríguez; Ruth Gómez-Caro; Joan De Jong; Carlos Martínez-A; Jan Paul Medema; Michael Hahne
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 5.  Belimumab in systemic lupus erythematosus.

Authors:  Andreia Vilas-Boas; Sandra A Morais; David A Isenberg
Journal:  RMD Open       Date:  2015-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.